基本信息
views: 54

Bio
目前已在J Am Chen Soc, Angew Chem Int Ed, J Med Chem, Chem Rev, Pharm Thera, APSB 等专业期刊发表SCI论文170余篇,他引2000余次。参与7部学术专著13个章节撰写。已申请国内外专利70余项,授权36项,包括国际专利14项。实现技术转让5项,4个候选新药正在进行临床前研究,3个新药已获得临床试验批件并先后进入临床I和II期试验。主持完成国家重大新药创制重大专项、基金委重点和面上项目、中科院国际合作前沿、中科院“战略先导A”、上海市重点重大等课题30余项。
Research Interests
Papers共 313 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of medicinal chemistry (2025)
Lin Zhang,Xian Zhao, Jingyan Hu, Tingting Li,Hong-Zhuan Chen,Ao Zhang,Hao Wang,Jianxiu Yu,Liang Zhang
Nature communicationsno. 1 (2025): 3966-3966
crossref(2025)
Yuqi Tang, Xinhua Pan,Fan-Fan Shang,Yang Li, Chaojun Zhang, Hexin Ma,Ao Zhang,Xu Wang,Chunyong Ding,Wantao Chen
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2025)
Yu-Xiao Xue, Yi-Jun Chen, Mei-Zhen Qin,Fan-Fan Shang, Yi-Ting Lu, Yu-Hao Sun,Liu-Guan Bian,Ao Zhang,Yang Yu,Chun-Yong Ding
Ancheng Shen, Xiyuan Wang, Qingxuan Chen,Yan Zhang,Fang Wang, Yuqiang Li,Zhiguo Liu,Liufu Deng, Wanli Ouyang,Meiyu Geng,Zilan Song,Zuoquan Xie,Ao Zhang
SENSORS AND ACTUATORS B-CHEMICAL (2025)
Xia Peng, Siqi Yu,Lin Xu,Qinghua Wang,Lin Yang, Yi Su, Zhirou Xiong, Mengjie Shao,Meiyu Geng,Ao Zhang,Lei Zhang,Jing Ai,Chunyong Ding
Molecules (Basel, Switzerland)no. 10 (2025)
Yifei Ma,Jiling Zeng,Fadian Ding,Yiwei Xu,Youlong Wang,Guanqing Zhong,Nianqi Liu,Yanqi Wang, Yiming Li,Shuqin Chen,Xiaolong Wei,Pengfei Zhu,Guangmin Jian, Yu Si Niu,Guangzhen Fu,Cantong Liu, Guiqiang Li, Xiaotong Zhou,Ao Zhang,Shangeng Weng
Journal of Nuclear Medicinepp.jnumed.123.267025-jnumed.123.267025, (2024)
Load More
Author Statistics
#Papers: 314
#Citation: 8301
H-Index: 48
G-Index: 75
Sociability: 7
Diversity: 4
Activity: 82
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn